Growth strategy, market assessment, and commercial due diligence engagements for clients in the pharmaceutical, biotech, and clinical diagnostic industriesSelect engagements include:-Precision oncology landscape assessment of twelve global markets for a pharmaceutical company-Growth strategy development for a clinical diagnostic company-Market assessment and forecast development of an oncology asset for a biotech company-Global commercial data strategy playbook development for a pharmaceutical company, focusing on oncology and vaccine therapeutic areas-Market assessment of infectious disease testing opportunity for a clinical diagnostic company-Pharmaceutical portfolio prioritization and development of asset specific investment / divestment recommendations for a pharmaceutical company

Responsible for leading client relationships and managing accounts across the pharmaceutical, clinical, and chemical materials industries to drive revenue growth of LC, LC-MS, MS/MS instrumentation, software, and consumablesIncreased territory sales by 33% year on year in both FY2017 and FY2018 and generated $18 million of revenue; finished in top 5% of Account Managers in North America in sales growth in both FY2017 and FY2018

Led laboratory group responsible for generation and management of analytical data for support of Phase III biologics as part of the Biologics Process Development and Commercialization team

Led analytical outsourcing as part of process characterization experiments and supported tech transfer of upstream production processes as part of the Biologics Manufacturing Science and Commercialization team

• Studied the mechanism of carbon monoxide dehydrogenase, a critical enzyme in the Wood-Ljungdahl pathway of carbon fixation by using molecular cloning techniques to mutate key amino acids sequences in gene and express the protein in methanogenic organisms.

• Used spike addition studies to assess the performance of various HPLC columns in an assay for determining polysorbate 20 concentrations in drug solutions. • Evaluated the feasibility of using solid phase extraction devices as a sample preparation technique for harvested cell culture fluid (HCCF).• Developed a two-dimensional assay utilizing HPLC to measure the concentrations of NADP and NADPH in HCCF for antibody reduction studies.